13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001913464
Total reported value
$118.0M
$118.0M
252 檔
10.4%
According to the latest 13F quarterly dataset, AlphaCentric Advisors LLC managed an equity portfolio of $118.0M at the end of Q1 2026, spanning 252 distinct U.S. exchange-listed positions.
In Q1 2026, AlphaCentric Advisors LLC displayed an active expansion posture, initiating 54 new positions and adding to 56 existing holdings, outstripping position reductions.
Showing top 200 holdings (of 252 total)
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | GILD | Gilead Sciences Inc | Stock-Healthcare | 2.82% | -0.63% | -6.90% | |
| 2 | RPV | Invesco S&p 500 Pure Value E | ETF-Large Cap & Growth | 2.56% | -1.39% | +38.78% | |
| 3 | IWD | Ishares Russell 1000 Value E | ETF-Other | 2.52% | -1.33% | +40.66% | |
| 4 | AZN | AstraZeneca PLC | Stock-Healthcare | 2.21% | -0.38% | — | |
| 5 | VRTX | Vertex Pharmaceuticals Inc | Stock-Healthcare | 2.20% | -0.09% | +5.75% | |
| 6 | EEFT | Euronet Worldwide Inc | Stock-Tech | 1.85% | -0.61% | — | |
| 7 | INVH | Invitation Homes Inc | Stock-Real Estate | 1.81% | +0.06% | -18.89% | |
| 8 | IONS | Ionis Pharmaceuticals Inc | Stock-Healthcare | 1.47% | -0.43% | +5.74% | |
| 9 | INSM | Insmed Inc | Stock-Healthcare | 1.45% | -0.39% | +16.95% | |
| 10 | INCY | Incyte CORP | Stock-Healthcare | 1.34% | +0.05% | +5.75% | |
| 11 | ROIV | Roivant Sciences Ltd. | Stock-Healthcare | 1.32% | +0.13% | +5.75% | |
| 12 | ARGX | Argenx Se - Adr | Stock-Healthcare | 1.31% | +0.11% | +25.89% | |
| 13 | NBIX | Neurocrine Biosciences Inc | Stock-Healthcare | 1.26% | +0.13% | +30.12% | |
| 14 | AXR | Amrep CORP | Stock-Other | 1.25% | -0.63% | -31.54% | |
| 15 | BFS | Saul Centers Inc | Stock-Other | 1.14% | -0.03% | +16.67% | |
| 16 | STXS | Stereotaxis Inc | Stock-Other | 1.10% | -0.23% | — | |
| 17 | AXSM | Axsome Therapeutics Inc | Stock-Healthcare | 1.09% | +0.26% | +5.75% | |
| 18 | ASND | Ascendis Pharma A/S | Stock-Other | 1.03% | -1.03% | EXIT | |
| 19 | AMPX | Amprius Technologies Inc | Stock-Other | 1.01% | -0.42% | +20.00% | |
| 20 | BHR 4.5 06-01-26Bond | Braemar Hotels & Resorts | Bond | 0.98% | -0.98% | EXIT | |
| 21 | APGE | Apogee Therapeutics Inc | Stock-Other | 0.96% | +0.34% | +5.75% | |
| 22 | PTGX | Protagonist Therapeutics Inc | Stock-Other | 0.95% | — | +5.74% | |
| 23 | CTO | Cto Realty Growth Inc | Stock-Other | 0.93% | -0.29% | +12.00% | |
| 24 | SMA | Smartstop Self Storage Reit | Stock-Other | 0.91% | -0.22% | +50.00% | |
| 25 | BLDR | Builders Firstsource Inc | Stock-Industrials | 0.82% | +0.13% | — | |
| 26 | AMGN | Amgen Inc | Stock-Healthcare | 0.82% | -0.10% | +5.77% | |
| 27 | INGM | Ingram Micro Holding CORP | Stock-Other | 0.81% | -0.75% | -15.92% | |
| 28 | RYTM | Rhythm Pharmaceuticals Inc | Stock-Other | 0.81% | +0.08% | +84.03% | |
| 29 | ISRG | Intuitive Surgical Inc | Stock-Healthcare | 0.81% | -0.22% | +16.67% | |
| 30 | SHY | Ishares 1-3 Year Treasury Bo | ETF-Gov Bonds | 0.78% | +0.12% | +171.87% | |
| 31 | IEI | Ishares 3-7 Year Treasury Bo | ETF-Gov Bonds | 0.77% | -0.25% | +171.17% | |
| 32 | ABBV | Abbvie Inc | Stock-Healthcare | 0.77% | — | +18.97% | |
| 33 | IEF | Ishares 7-10 Year Treasury B | ETF-Gov Bonds | 0.77% | -0.47% | +170.86% | |
| 34 | ROK | Rockwell Automation Inc | Stock-Industrials | 0.72% | +0.12% | — | |
| 35 | BIIB | Biogen Inc | Stock-Healthcare | 0.70% | +0.01% | +5.73% | |
| 36 | PNNT | Pennantpark Investment CORP | Stock-Other | 0.70% | +0.04% | — | |
| 37 | SNY | Sanofi-adr | Stock-Healthcare | 0.69% | -0.16% | +5.80% | |
| 38 | JAZZ | Jazz Pharmaceuticals plc | Stock-Healthcare | 0.67% | +0.07% | +5.73% | |
| 39 | AVAV | Aerovironment Inc | Stock-Industrials | 0.67% | -0.16% | +45.76% | |
| 40 | SYM | Symbotic Inc | Stock-Industrials | 0.66% | -0.09% | — | |
| 41 | AEVA | Aeva Technologies Inc | Stock-Other | 0.66% | +0.56% | — | |
| 42 | LUNR | Intuitive Machines Inc | Stock-Other | 0.65% | -0.20% | -30.00% | |
| 43 | GMED | Globus Medical Inc - A | Stock-Healthcare | 0.65% | +0.02% | -13.91% | |
| 44 | AAT | American Assets Trust Inc | Stock-Other | 0.64% | -0.01% | — | |
| 45 | SERV | Serve Robotics Inc | Stock-Other | 0.63% | -0.07% | — | |
| 46 | AHRT | Ah Realty Trust Inc | Stock-Other | 0.63% | +0.06% | +91.67% | |
| 47 | EWA | Ishares Msci Australia ETF | ETF-Other | 0.61% | -0.05% | -2.66% | |
| 48 | BBJP | Jpmorgan Betabuilders Japan | ETF-Other | 0.61% | -0.03% | -2.08% | |
| 49 | PDYN | Palladyne Ai CORP | Stock-Other | 0.61% | -0.09% | — | |
| 50 | RCAT | Red Cat Holdings Inc | Stock-Other | 0.59% | -0.14% | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | RPV | Invesco S&p 500 Pure Value E | +0.8% | +38.78% | Add |
| 2 | IWD | Ishares Russell 1000 Value E | +0.8% | +40.66% | Add |
| 3 | AMPX | Amprius Technologies Inc | +0.6% | +20.00% | Add |
| 4 | SHY | Ishares 1-3 Year Treasury Bo | +0.5% | +171.87% | Add |
| 5 | IEF | Ishares 7-10 Year Treasury B | +0.5% | +170.86% | Add |
| 6 | IEI | Ishares 3-7 Year Treasury Bo | +0.5% | +171.17% | Add |
| 7 | ROIV | Roivant Sciences Ltd. | +0.4% | +5.75% | Add |
| 8 | ASND | Ascendis Pharma A/S | +0.3% | +39.78% | Add |
| 9 | SMA | Smartstop Self Storage Reit | +0.3% | +50.00% | Add |
| 10 | L | Loews CORP | +0.3% | +203.18% | Add |
| 11 | RYTM | Rhythm Pharmaceuticals Inc | +0.3% | +84.03% | Add |
| 12 | HCA | Hca Healthcare Inc | +0.2% | +185.07% | Add |
| 13 | MGTX | MeiraGTx Holdings plc | +0.2% | +88.43% | Add |
| 14 | AHRT | Ah Realty Trust Inc | +0.2% | +91.67% | Add |
| 15 | ORKA | Oruka Therapeutics Inc | +0.2% | +5.75% | Add |
| 16 | T | At&t Inc | +0.2% | +53.46% | Add |
| 17 | NBIX | Neurocrine Biosciences Inc | +0.2% | +30.12% | Add |
| 18 | PTGX | Protagonist Therapeutics Inc | +0.2% | +5.74% | Add |
| 19 | BFS | Saul Centers Inc | +0.2% | +16.67% | Add |
| 20 | VZ | Verizon Communications Inc | +0.2% | +133.84% | Add |
| 21 | PDYN | Palladyne Ai CORP | +0.2% | — | Unchanged |
| 22 | GILD | Gilead Sciences Inc | +0.2% | -6.90% | Trim |
| 23 | APGE | Apogee Therapeutics Inc | +0.2% | +5.75% | Add |
| 24 | GL | Globe Life Inc | +0.1% | +113.76% | Add |
| 25 | KGC | Kinross Gold CORP | +0.1% | +48.26% | Add |
| 26 | INSM | Insmed Inc | +0.1% | +16.95% | Add |
| 27 | EWTX | Edgewise Therapeutics Inc | +0.1% | +6.20% | Add |
| 28 | CAH | Cardinal Health Inc | +0.1% | +43.57% | Add |
| 29 | ARGX | Argenx Se - Adr | +0.1% | +25.89% | Add |
| 30 | AGIO | Agios Pharmaceuticals Inc | +0.1% | +6.32% | Add |
| 31 | IVZ | Invesco Ltd. | +0.1% | +71.10% | Add |
| 32 | CTO | Cto Realty Growth Inc | +0.1% | +12.00% | Add |
| 33 | JAZZ | Jazz Pharmaceuticals plc | +0.1% | +5.73% | Add |
| 34 | AMGN | Amgen Inc | +0.1% | +5.77% | Add |
| 35 | ABBV | Abbvie Inc | +0.1% | +18.97% | Add |
| 36 | CGEM | Cullinan Therapeutics Inc | +0.1% | +5.75% | Add |
| 37 | COR | Cencora Inc | +0.1% | +35.68% | Add |
| 38 | VRTX | Vertex Pharmaceuticals Inc | +0.1% | +5.75% | Add |
| 39 | B | Barrick Mining CORP | +0.1% | +63.44% | Add |
| 40 | MBOT | Microbot Medical Inc | +0.1% | — | Unchanged |
| 41 | SION | Sionna Therapeutics Inc | +0.1% | +77.13% | Add |
| 42 | TECX | Tectonic Therapeutic Inc | +0.1% | +5.76% | Add |
| 43 | CPRX | Catalyst Pharmaceuticals Inc | +0.1% | +5.75% | Add |
| 44 | AVAV | Aerovironment Inc | +0.1% | +45.76% | Add |
| 45 | BIIB | Biogen Inc | +0.1% | +5.73% | Add |
| 46 | BKLN | Invesco Senior Loan ETF | +0.1% | +17.28% | Add |
| 47 | RZLT | Rezolute Inc | +0.1% | +6.22% | Add |
| 48 | CF | Cf Industries Holdings Inc | +0.1% | +4.02% | Add |
| 49 | NEM | Newmont CORP | +0.1% | +5.22% | Add |
| 50 | NRIX | Nurix Therapeutics Inc | +0.1% | +41.01% | Add |
According to official SEC Form 13F filings, AlphaCentric Advisors LLC reported a total U.S. public equity portfolio value of $118.0M across 252 disclosed positions in Q1 2026.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including GILD, RPV, IWD) accounted for 10.4% of total reported equity market value during Q1 2026.
Top New Position Initiated
AZN
市值: $2.2M
Top Position Liquidated / Trimmed
MBB
前期市值: $2.5M
During Q1 2026, AlphaCentric Advisors LLC's top holdings by market value included GILD (2.8%)、RPV (2.6%)、IWD (2.5%). The largest single position, GILD, represented 2.8% of total portfolio value.
In Q1 2026, AlphaCentric Advisors LLC made 189 total portfolio adjustments, initiating 54 new buys, adding to 56 positions, trimming 30 holdings, and fully liquidating 49 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.